19th Dec 2008 10:58
RNS Number : 4751K
Physiomics PLC
19 December 2008
Physiomics plc
The Magdalen Centre
The Oxford Science ParkRobert Robinson AvenueOxford
OX4 4GAUK
Tel 01865 784980
Fax 08701 671931
19 December 2008
Physiomics plc ("Physiomics" or "the Company")
The Company is pleased to announce that all resolutions put to shareholders at the Annual General Meeting held today were passed.
For further information:
Physiomics plc +44 (0)7747 842446
Dr Paul Harper, Chairman
Grant Thornton UK LLP +44 (0)20 7383 5100
Philip Secrett, Colin Aaronson
About Physiomics plc
Physiomics plc (AIM:PYC) is a computational systems biology services company applying simulations of cell behaviour to drug development to reduce the high attrition rates of clinical trials. As 80-90 per cent of all clinical drug candidates fail to reach the market, estimates1 show that an overall ten per cent improvement in success rates could reduce the cost of one drug's development by as much as $242 million, from the current estimate of around $800 million.
Physiomics develops computational systems biology models to predict and understand cancer drug efficacy from pre-clinical research to clinical development. Physiomics has created detailed mathematical models incorporating most important molecular events taking place during the human cell cycle and apoptosis processes. Physiomics developed SystemCell® technology, a multi-cellular environment software, which enables the simulation of population of "virtual cells".
Physiomics, based in Oxford, UK, was founded in 2001, and floated on AIM in 2004. For further information, please visit www.physiomics-plc.com
SystemCell® is a registered trademark of Physiomics plc
1Tufts Centre Impact Report 2002
This information is provided by RNS
The company news service from the London Stock Exchange
Related Shares:
Physiomics